CBD Nanoemulsion Reduced Both Anxiety and Panic Responses in Rats at Lower Doses
A lipid-based CBD nanoemulsion produced both anxiety-reducing and panic-reducing effects in rats after chronic treatment at 2.5 mg/kg, working through serotonin neurons in the dorsal raphe.
Quick Facts
What This Study Found
Chronic oral CBD nanoemulsion (2.5 mg/kg for 21 days) produced anxiolytic and panicolytic effects in rats tested on the elevated T-maze. The effects were linked to increased activity in serotonin-producing neurons of the dorsal raphe nucleus. Acute CBD showed no behavioral effects. Brain tissue analysis confirmed CBD reached the brain at measurable concentrations.
Key Numbers
CBD 2.5 mg/kg yielded 64.25 ng CBD/g brain tissue; CBD 5.0 mg/kg yielded 21.22 ng/g. Only the 2.5 mg/kg dose showed behavioral effects. 21 days of chronic treatment needed.
How They Did This
Male Wistar rats received oral CBD nanoemulsion (2.5 or 5 mg/kg) or vehicle daily for 21 days. Behavioral testing used the elevated T-maze. Brain CBD levels were measured. Immunohistochemistry examined FosB/deltaFosB expression and tryptophan hydroxylase in the dorsal raphe and periaqueductal gray.
Why This Research Matters
CBD's poor oral bioavailability has been a major barrier to clinical use. Nanoemulsion formulations can improve absorption, potentially allowing lower effective doses. This study shows a nanoemulsion CBD formulation produced anti-anxiety and anti-panic effects at relatively low doses in rats.
The Bigger Picture
The finding that a lower dose (2.5 mg/kg) was more effective than a higher dose (5.0 mg/kg) aligns with CBD's known biphasic dose-response pattern. The nanoemulsion delivery format could improve clinical translation.
What This Study Doesn't Tell Us
Animal study in male rats only. Only two doses tested. Inverted dose-response needs further investigation. Nanoemulsion formulation may not translate directly to human use.
Questions This Raises
- ?Why was the lower CBD dose more effective than the higher dose?
- ?Would CBD nanoemulsions show similar anti-anxiety effects in humans?
- ?Could this formulation approach reduce the high CBD doses typically needed for clinical effects?
Trust & Context
- Key Stat:
- 2.5 mg/kg chronic CBD nanoemulsion reduced both anxiety and panic
- Evidence Grade:
- Preliminary: animal study with novel formulation, detailed mechanistic work but no human data.
- Study Age:
- Published in 2025.
- Original Title:
- A cannabidiol (CBD) lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases FosB/deltaFosB immunoreactivity in serotonergic cells of the dorsal raphe.
- Published In:
- Brain research, 1864, 149791 (2025)
- Authors:
- Rosário, Bárbara A, de Lima, Maria Paula, Vieira, Márcio G, Leite, Laís Garret, de Aquino, Pedro E A, Viana, Glauce S B, Silveira, Edilberto R, de Brito, Débora H A, Zampieri, Dávila, Ricardo, Nágila Maria P S, Lemes, Jéssica A, Tucci, Adriana M, Ribeiro, Daniel A, Viana, Milena B
- Database ID:
- RTHC-07522
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can CBD help with panic attacks?
In this rat study, chronic CBD nanoemulsion treatment reduced both anxiety-like and panic-like behaviors. The effects were linked to changes in serotonin neurons, suggesting a specific neural mechanism.
Does the form of CBD matter for its effects?
This study used a lipid nanoemulsion to improve CBD absorption. The formulation allowed lower doses to reach the brain and produce behavioral effects, suggesting delivery method matters.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07522APA
Rosário, Bárbara A; de Lima, Maria Paula; Vieira, Márcio G; Leite, Laís Garret; de Aquino, Pedro E A; Viana, Glauce S B; Silveira, Edilberto R; de Brito, Débora H A; Zampieri, Dávila; Ricardo, Nágila Maria P S; Lemes, Jéssica A; Tucci, Adriana M; Ribeiro, Daniel A; Viana, Milena B. (2025). A cannabidiol (CBD) lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases FosB/deltaFosB immunoreactivity in serotonergic cells of the dorsal raphe.. Brain research, 1864, 149791. https://doi.org/10.1016/j.brainres.2025.149791
MLA
Rosário, Bárbara A, et al. "A cannabidiol (CBD) lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases FosB/deltaFosB immunoreactivity in serotonergic cells of the dorsal raphe.." Brain research, 2025. https://doi.org/10.1016/j.brainres.2025.149791
RethinkTHC
RethinkTHC Research Database. "A cannabidiol (CBD) lipid-based nanoemulsion induces anxioly..." RTHC-07522. Retrieved from https://rethinkthc.com/research/rosario-2025-a-cannabidiol-cbd-lipidbased
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.